CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
Subscribe
CONNECTIVITY
INJECTION
OCULAR
ORAL
RESPIRATORY
SKIN
MORE
COVID-19 NEWS
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
SEARCH
SEARCH
advanced search
Connecting Drug Delivery
98
Issue No #98 Jun 2019
June 7th, 2019
Download PDF
Inside the magazine
EXPERT VIEW
Shaul Eitan
CUSTOMISED INFUSION PUMPS: THE FUTURE OF SELF-ADMINISTRATION?
Shaul Eitan explores the challenges of home infusion and examines how customisation and connectivity could help provide a solution.
CONNECTIVITY
Dr Andreas Schneider
Ypsomed
I SPY WITH MY LITTLE EYE: EYE TRACKING DRIVES PATIENT-CENTRED DEVELOPMENT OF CONNECTED SYSTEMS
The development of connected self-injection systems is driving industry to rethink its current approaches to patient-centred new product development. Andreas Schneider summarises a recent field study that used eye tracking for the formative usability testing of SmartPilot for YpsoMate.
CONNECTIVITY
Dr Ramin Rafiei
SHL Medical
MACRO TRENDS ACCELERATING THE ADOPTION OF CONNECTIVITY IN DRUG DELIVERY
Ramin Rafiei argues that connected therapeutics – the augmentation of drugs through sensors and connectivity – are now a clinical source for real-world data and provide an opportunity to bridge the efficacy-to-effectiveness gap. This next frontier in drug delivery, powered by connected therapeutics, will be data-driven, personalised, outcomes-based and accessible.
CONNECTIVITY
Eric Dessertenne
Biocorp
COMPLETING ITS TRANSITION FROM GENESIS TO MATURITY, BIOCORP OPENS NEW HORIZONS
As Biocorp prepares for the market launch of its connected injector pen add-on, Mallya, Eric Dessertenne and Arnaud Guillet share insights about key steps in the company’s development. The article discusses the many partnership Biocorp has entered in to, and includes a mini-interview with Sergio Monti, Plant Manager for one such partner, V.A.R.I.
CONNECTIVITY
Thierry Decock
Nemera
CONNECTED DEVICES – MEDICATION DELIVERY JUST GOT PERSONAL
Thierry Decock and Hadrien Gremillet explore how the obstacles to the adoption of connectivity can be overcome and how connected devices can deliver truly patient-centric care that will clearly improve adherence rates, whilst demonstrating a clear cost benefit to the pharmaceutical partner.
INTERVIEW
Dr Mircea Despa
BD (Becton Dickinson & Company)
MIRCEA DESPA & DOUG McCLURE, BD
In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.
CONNECTIVITY
Dr Benjamin Jung
H&T Presspart
THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A NETWORK PERSPECTIVE
Benjamin Jung uses a network theory approach to look at the ongoing issue of adherence when it comes to the treatment of asthma and COPD, and the players involved in overcoming it.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY RESTORING TRUST IN PHARMA COMMUNICATIONS
Napoleon Monroe analyses connectivity coverage at recent drug delivery conferences and, more broadly, in various publications, to evaluate the current direction, and explore the scope for connectivity to effect changes benefiting multiple stakeholders across a range of treatment categories.
CONNECTIVITY
Matt Jones
DCA
DON’T DEVELOP A CONNECTED DRUG DELIVERY DEVICE WITHOUT READING THIS
Matt Jones summarises some of the key challenges and opportunities in the development of connected drug delivery devices, focusing in detail on deciding what a connected drug delivery device should do, designing for a coin cell, direct cellular connection and antenna design.
EXPERT VIEW
Mark Tunkel
USER-CENTRED DEVICE CONNECTIVITY
Mark Tunkel and Carolyn Rose discuss the benefits of taking a user-needs approach, and mapping the patient journey, in a connectivity strategy.
EXPERT VIEW
Tim Frearson
PUSHING THE BOUNDARIES OF INFUSION PUMP INTEROPERABILITY
Interoperability is not a new concept for infusion pumps. But in many cases hospitals have been slow to embrace the full potential of connectivity. When is this likely to change? What will hospitals need when it does? And where should infusion pump manufacturers focus innovation efforts in the meantime? Tim Frearson considers the options.
CONNECTIVITY
Neil Williams
Phillips-Medisize
LOW-COST CONNECTIVITY MEETS PATIENT & PHARMA MEDICATION MANAGEMENT NEEDS
Neil Williams describes the potential connected drug delivery systems hold to address serious challenges in healthcare, including poor adherence, and also deliver substantial value, and outlines the company’s highly scalable enterprise platform, the Connected Health Platform.
CONNECTIVITY
Craig Baker
Noble
ADHERENCE TO SELF-INJECTION REGIMENS CAN BE ENHANCED BY CONNECTED DEVICES
Craig Baker looks at the factors contributing to non-adherence and explores how connected devices can help patients follow their self-injection regimens.
CONNECTIVITY
Tsachi Shaked
E3D – Elcam Drug Delivery Devices
ADDING CONNECTIVITY TO DRUG DELIVERY DEVICES
Tsachi Shaked explores how – as the trend towards moving healthcare from the hospital to the home continues – connectivity in drug delivery devices may be changing from being the exception to the rule.
Top
This website uses functional cookies (but not advertising cookies). View our
Privacy Policy
.
Close
Privacy & Cookies Policy
Close
Necessary
Always Enabled